ONCY

#3924
Oncolytics Biotech, Inc. Common Shares
1.02 USD
-2.86%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.02
1.02
Intervallo Annuale
0.33
1.51
Variazione giornaliera
-2.86%
Variazione Mensile
+3.03%
Variazione di 6 mesi
-15.00%
Variazione Annuale
+72.88%
Chiusura Precedente
1.05
Apertura
1.02
Bid
Ask
Minimo
1.02
High
1.02
Volume
11
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 118.45 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.91
Rapporto prezzo/fatturato
-169.59

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Notizie